Wednesday, September 13, 2023 12:15 AM
SAN RAMON, Calif.—CooperCompanies
(NYSE: COO) announced that it will transfer the listing of its common stock from the New York Stock Exchange (“NYSE”) to the Nasdaq Stock Market (“Nasdaq”). Cooper expects to begin trading as a Nasdaq-listed company at market open on September 26, 2023, and will continue to trade under the symbol COO. “We are excited to join many of the world’s largest and most innovative companies on Nasdaq,” said Al White, president and CEO of CooperCompanies.
Tuesday, September 12, 2023 12:15 AM
VAUGHAN, Ontario—Bausch + Lomb Corporation
(NYSE/TSX: BLCO), a leading global eye health company, announced that Bausch + Lomb Escrow Corp., a wholly owned subsidiary of the company, has launched an offering of $1.4 billion aggregate principal amount of new senior secured notes due in 2028 and that the company is seeking to enter into an incremental term loan facility, in each case in connection with the financing of its pending acquisition of Xiidra (lifitegrast ophthalmic solution) 5%, a non-steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease focusing on inflammation associated with dry eye and certain other ophthalmology assets.
Friday, September 8, 2023 12:24 AM
BATH, England—Inspecs Group plc
(LSE: SPEC), a global eyewear and lens design house and manufacturer, presented its unaudited interim results for the six months ended June 30, 2023.
Friday, September 1, 2023 12:24 AM
HAMBURG, Germany and DETROIT—The Fielmann Group
(ETR: FIE), a leading European eyewear retailer, said it closed on its acquisition of SVS Vision
yesterday. The complementary acquisition of online retailer Befitting
had already closed in June. These previously reported
acquisitions constitute an important milestone in the internationalization that the German family business is pursuing with its Vision 2025 growth strategy, the announcement noted, adding "U.S. acquisitions constitute the first step in a long-term plan to empower U.S. eyewear customers."
Thursday, August 31, 2023 12:24 AM
SAN RAMON, Calif.—CooperCompanies
(NYSE: COO) announced late yesterday financial results for its fiscal third quarter ended July 31, 2023. Revenue increased 10 percent year-over-year to $930.2 million. CooperVision (CVI) revenue was up 11 percent to $630.2 million, and CooperSurgical (CSI) revenue increased 8 percent to $300.0 million. Commenting on the results, Al White, Cooper's president and CEO said, "We're very pleased to report another strong quarter with record quarterly revenues at both CooperVision and CooperSurgical. Our performance reflects the successful execution of our strategic growth initiatives which would not be possible without the dedication and incredible hard work of our Cooper teams around the world."
Thursday, August 17, 2023 12:24 AM
(SIX/NYSE:ALC) reported its financial results for the three and six months ended June 30, 2023. For the second quarter of 2023, sales were $2.4 billion, an increase of 9 percent on a reported basis and 12 percent on a constant currency basis as compared to the same quarter of the previous year. Sales for the first half of 2023 were $4.7 billion, an increase of 8 percent on a reported basis and 11 percent on a constant currency basis, compared to the first half of 2022.
Tuesday, August 15, 2023 12:27 AM
VANCOUVER, British Columbia—KITS Eyecare Ltd.
(TSX: KITS), a vertically integrated eyecare provider, reported results for the second quarter ended June 30, 2023. Revenue increased 38 percent to $30.0 million compared to $21.8 million in the prior year. The increase was primarily attributable to an increase in eyeglasses delivered, strong repeat customer revenue and growth in first-time eyeglass customers. For the six months ended June 30, 2023, compared to the six months ended June 30, 2022, revenue increased 38 percent to $57.7 million compared to $41.8 million.
Monday, August 14, 2023 12:24 AM
ORLANDO, Fla.—Lensar, Inc.
, a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, announced financial results for the quarter ended June 30, 2023.
Friday, August 11, 2023 12:24 AM
DULUTH, Ga.—National Vision Holdings
(NASDAQ: EYE) yesterday posted net revenue of $525.3 million for the second quarter ended July 1, 2023, up 3.1 percent from Q2 2022.
Friday, August 11, 2023 12:18 AM
(Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, yesterday reported record revenues of $33.5 million for the second quarter and six months ended June 30, 2023.
Thursday, August 10, 2023 12:24 AM
NEW YORK—Warby Parker Inc.
(NYSE: WRBY) announced financial results for the second quarter ended June 30, 2023. Net revenue increased $16.5 million, or 11.0 percent, to $166.1 million.
Monday, August 7, 2023 12:21 AM
JENA, Germany—Carl Zeiss Meditec
reported further revenue growth for the first nine months of its fiscal year, with revenues of what it says was around €1,509.6 million in the first nine months of fiscal year 2022/23.
Monday, August 7, 2023 12:15 AM
ALISO VIEJO, Calif.—Glaukos Corp.
(NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced financial results for the second quarter ended June 30, 2023. Net sales of $80.4 million in Q2 2023 increased 11 percent year-over-year. Glaucoma net sales of $61.9 million in Q2 2023 increased 10 percent year-over-year while corneal health net sales of $18.5 million in Q2 2023 increased 11 percent year-over-year.
Thursday, August 3, 2023 1:52 PM
Does employee engagement get a boost from profit-sharing plans? Sixty-three percent of the respondents (63 percent) to a recent Women In Optometry
Pop-up Poll thought it would. The second most common reason was also related to staffing; 54 percent of respondents said that they implemented such a plan to help with employee recruitment and retention.
Nearly 46 percent said that a profit-sharing plan can contribute to financial growth of the business. Others wrote in that they implemented such a plan to help with their own personal retirement planning or simply that it’s fun.
A slim majority of respondents—54 percent—do not have a profit-sharing option in their practice or business. Most of the respondents (82 percent) were in private, unaffiliated practices, and a similar percentage were directly involved in profit-sharing and other financial decisions.